News OneSource Specialty Pharma Limited

Stocks

ONESOURCE

INE013P01021

Biotechnology & Medical Research

Market Closed - NSE India S.E. 07:05:09 2026-10-29 EDT			5-day change	1st Jan Change
1,569.60 ^INR	-0.51%		+15.66%	-13.31%

10-27	OneSource Specialty Pharma Limited, Q2 2027 Earnings Call, Oct 27, 2026
10-27	OneSource Specialty Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026	CI

All News

Mentions Relevance

10-27	OneSource Specialty Pharma Limited, Q2 2027 Earnings Call, Oct 27, 2026
10-27	OneSource Specialty Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026	CI
10-23	Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption	RE
10-11	Middle East Pharmaceutical Industries Co. And OneSource Specialty Pharma Limited Announce Signing Of A License Agreement For Tirzepatide, A Generic Of Mounjaro® KwikPen®, In The Kingdom Of Saudi Arabia And The MENA Region	CI
07-24	OneSource Specialty Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
07-24	OneSource Specialty Pharma Limited Announces Executive Changes, Effective July 24, 2026	CI
07-19	OneSource Specialty Pharma Limited Recalls Methohexital Sodium for Injection	CI
07-14	Formycon Ag and Onesource Specialty Pharma Limited Announce Strategic Manufacturing Partnership for Biosimilars	CI
05-13	Onesource Specialty Pharma not to pursue merger of facilities of Steriscienceat with co	RE
05-13	Onesource Specialty Pharma March-quarter consol profit 46 million rupees	RE
05-13	OneSource Specialty Pharma Limited Announces Resignation of Prateek Gupta as SVP & Head Technical Development, Effective May 13, 2026	CI
05-13	OneSource Specialty Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-03	OneSource Specialty Pharma Limited and Orbicular Receives Approval from Health Canada for A Generic Version of Ozempic	CI
04-21	OneSource Specialty Pharma's Partner Gets US FDA Nod for Generic Version of Ozempic	MT
04-21	Onesource Specialty Pharma says Orbicular secures tentative U.S. FDA ANDA approval for generic Ozempic	RE
04-17	Onesource Specialty Pharma says EU-GMP certification for Unit II manufacturing facility renewed	RE
02-10	OneSource Specialty Pharma Gets Approval to Commercialize Generic Version of Ozempic in Saudi Arabia	MT
02-10	Onesource Specialty says Onesource-Hikma secures approval to commercialise generic Ozempic in Saudi Arabia	RE
02-10	OneSource Specialty Pharma Limited Announces That It Has Received Saudi Food and Drug Authority Approval of Its Generic Ozempic®? (Semaglutide) in Saudi Arabia	CI
01-23	OneSource Specialty Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
01-23	Onesource Specialty Pharma posts Dec-quarter consol loss of 887 million rupees	RE
11-11	OneSource Specialty Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-08-04	OneSource Specialty Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-07-07	Onesource Specialty Pharma Limited Appoints Jeffrey Wong as Chief Business Officer, Effective Date Is July 7, 2025	CI
25-06-12	India's OneSource eyes weight-loss drug boost to order book	RE